Marshall Wace Portfolio holdings
AUM
$84.1B
1-Year Return
27.54%
This Quarter Return
+12.85%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$52.4B
AUM Growth
+$5.78B
(+12%)
Cap. Flow
-$58M
Cap. Flow
% of AUM
-0.11%
Top 10 Holdings %
Top 10 Hldgs %
29.33%
Holding
2,582
New
588
Increased
468
Reduced
671
Closed
597
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.66B |
| 2 |
Amazon
AMZN
|
+$651M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$430M |
| 4 |
D.R. Horton
DHI
|
+$376M |
| 5 |
Intel
INTC
|
+$373M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$956M |
| 2 |
NVIDIA
NVDA
|
+$633M |
| 3 |
Advanced Micro Devices
AMD
|
+$549M |
| 4 |
Amgen
AMGN
|
+$406M |
| 5 |
Adobe
ADBE
|
+$396M |
Sector Composition
| 1 | Technology | 16.81% |
| 2 | Consumer Discretionary | 14.92% |
| 3 | Healthcare | 14.13% |
| 4 | Financials | 8.27% |
| 5 | Communication Services | 7.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Ashland
ASH
$2.5B
| $588K | ﹤0.01% |
6,979
-7,958
| -53% | -$671K |
|
1352
SolarEdge
SEDG
$1.75B
| $587K | ﹤0.01% |
+6,270
| New | +$587K |
|
1353
Aquestive Therapeutics
AQST
$599M
| $584K | ﹤0.01% |
288,884
-21,925
| -7% | -$44.3K |
|
|
NOAH
1354
Noah Holdings
NOAH
$793M
| $584K | ﹤0.01% |
42,254
+20,138
| +91% | +$278K |
|
|
BWAY
1355
Brainsway
BWAY
$297M
| $581K | ﹤0.01% |
+89,631
| New | +$581K |
|
1356
Franklin Covey
FC
$246M
| $580K | ﹤0.01% |
13,321
-1,662
| -11% | -$72.3K |
|
1357
Criteo
CRTO
$1.15B
| $579K | ﹤0.01% |
+22,881
| New | +$579K |
|
1358
Freshworks
FRSH
$3.76B
| $578K | ﹤0.01% |
24,596
-6,162
| -20% | -$145K |
|
1359
Viant Technology
DSP
$162M
| $578K | ﹤0.01% |
83,844
-77,049
| -48% | -$531K |
|
1360
Digimarc
DMRC
$198M
| $577K | ﹤0.01% |
15,979
-33,092
| -67% | -$1.2M |
|
1361
AvidXchange
AVDX
$2.06B
| $576K | ﹤0.01% |
+46,500
| New | +$576K |
|
1362
MKS Inc. Common Stock
MKSI
$7.79B
| $576K | ﹤0.01% |
+5,600
| New | +$576K |
|
1363
Transcat
TRNS
$712M
| $576K | ﹤0.01% |
5,269
-18,695
| -78% | -$2.04M |
|
1364
Oxford Industries
OXM
$770M
| $573K | ﹤0.01% |
5,732
-32,428
| -85% | -$3.24M |
|
1365
Zoetis
ZTS
$66.7B
| $572K | ﹤0.01% |
2,900
-170,135
| -98% | -$33.6M |
|
1366
Hilton Grand Vacations
HGV
$4.07B
| $572K | ﹤0.01% |
14,226
-425,713
| -97% | -$17.1M |
|
1367
Enact Holdings
ACT
$5.79B
| $571K | ﹤0.01% |
19,780
-137,158
| -87% | -$3.96M |
|
|
EU
1368
enCore Energy
EU
$438M
| $571K | ﹤0.01% |
+145,356
| New | +$571K |
|
1369
CI&T Inc
CINT
$686M
| $570K | ﹤0.01% |
108,393
-147,807
| -58% | -$777K |
|
1370
Arhaus
ARHS
$1.58B
| $570K | ﹤0.01% |
48,100
-791,400
| -94% | -$9.38M |
|
1371
Golub Capital BDC
GBDC
$3.94B
| $568K | ﹤0.01% |
+37,619
| New | +$568K |
|
1372
Algoma Steel
ASTL
$484M
| $566K | ﹤0.01% |
+56,451
| New | +$566K |
|
1373
Williams-Sonoma
WSM
$24.8B
| $565K | ﹤0.01% |
+5,600
| New | +$565K |
|
1374
Equinix
EQIX
$78B
| $564K | ﹤0.01% |
+700
| New | +$564K |
|
1375
CytomX Therapeutics
CTMX
$345M
| $563K | ﹤0.01% |
363,276
-14,317
| -4% | -$22.2K |
|